期刊名称：ATHEROSCLEROSIS SUPPLEMENTS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Official Journal of the European Atherosclerosis Society
Affiliated with the International Atherosclerosis Society and the Society of Atherosclerosis Imaging and Prevention
Atherosclerosis brings together from all sources papers concerned with research and investigation on atherosclerosis, its complications, and related diseases, including: lipoprotein metabolism, arterial and vascular biology and disease, thrombosis, inflammation, disorders of lipid transport, diabetes and hypertension as related to atherosclerosis, and cardiovascular risk factors. ... click here for full Aims & Scope
Atherosclerosis brings together from all sources papers concerned with research and investigation on atherosclerosis, its complications, and related diseases, including: lipoprotein metabolism, arterial and vascular biology and disease, thrombosis, inflammation, disorders of lipid transport, diabetes and hypertension as related to atherosclerosis, and cardiovascular risk factors. The editors are also interested in clinical papers dealing with case studies of specific or general interest, new or unusual lipid syndromes, and the genetic basis and familial incidence of atherosclerosis and related diseases. High quality reports of controlled clinical trials of drugs or diets will be considered provided the paper deals with the mechanism of action of the drug or diet.
Complimentary online access is available to all members of the European Atherosclerosis Society and EAS 2010 Hamburg Congress delegates.
A reduced personal subscription rate is available to all members of the International Atherosclerosis Society and the Society of Atherosclerosis Imaging and Prevention.
Please apply to the Publisher for more information.
Electronic usage:
An increasing number of readers access the journal online via ScienceDirect, one of the world's most advanced web delivery systems for scientific, technical and medical information.
Instructions to Authors
Manuscripts
Original articles should report original research not previously published or being considered for publication elsewhere. Please note, suspected cases of plagiarism or manipulation of data will be dealt with in consultation with the communicating author and the relevant authorities (please see below). Manuscripts should be written in the English language (using either American or British spelling).
The number of words per manuscript should not exceed 4000 (including tables and legends to figures).
As a rule, research papers should be divided into sections, headed by a caption (e.g. Abstract, Introduction, Materials, Methods, Experimental Results, Discussion, etc.).
Please include a short paragraph of conclusions (at the end of the text), indicating the relevance of the study with regard to the basics and/or clinical aspect of atherosclerosis. A statement concerning the source of funding, conflicts of interests and disclosures of financial support is highly recommended.
Essential title page information
• Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.
• Author names and affiliations. Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name, and, if available, the e-mail address of each author.
• Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that telephone and fax numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address.
• Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a "Present address" (or "Permanent address") may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
Abstracts
A structured abstract (objective, methods, results and conclusion) of 50-250 words must be included.
Keywords
A keyword summary must be provided; normally 3-7 items should be included. Authors are encouraged to choose their own keywords but, if in grave doubt which items to select, Medical Subject Headings (issued with the January Index Medicus, 1969) may be used as a guideline.
Tables
Tables with titles and legends must be on separate pages with double spacing. Authors must list on the title page or in the covering e-mail, the number of figures and/or tables to be found in the paper.
References
References must be given at the end of the paper, numbered in the order in which they appear in the text and quoted in the text at appropriate places. The number of references must not exceed 30 (except for Reviews).
They should be arranged as follows: Authors (second name and initial of first name(s), e.g. Mailhac A, Badimon JJ), title of article (upper case only on first word or proper nouns/names), title of journal (standard abbreviation if possible), year of publication, volume number of journal and page range (e.g. 1432-6).
References to books should include: Author's and/or Editor's name(s), title of book, place of publication, publisher, year, page numbers (if necessary). This journal should be cited as Atherosclerosis.
Reference management software
This journal has standard templates available in key reference management packages EndNote ( http://www.endnote.com) and Reference Manager ( http://www.refman.com). Using plug-ins to wordprocessing packages, authors only need to select the appropriate journal template when preparing their article and the list of references and citations to these will be formatted according to the journal style which is described below.
DNA sequences and GenBank accession numbers
For each and every gene accession number cited in an article, Authors must type the accession number in bold underlined text. Letters in the accession number must always be capitalised.
Example: (GenBank accession nos. AI631510 , AI631511 , AI632198 , and BF223228 ), a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048 ), and a T-cell lymphoma (GenBank accession no. AA361117 ).
For all gene variants the rs number must be provided. Current standard nomenclature for designation of DNA sequence variants must be adhered to: http://www.hgvs.org. In order to allow for the work to be reproduced by others, where not previously published, authors are encouraged to provide as supplementary material for web-publication only, the primers and PCR conditions for all variants genotyped in the manuscript.
Supplementary Data
Elsevier accepts electronic supplementary material (e-components) to support and enhance presentation of your scientific research. Supplementary files offer the Author additional possibilities to publish supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable, please ensure that data is provided in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption for each file. For more detailed instructions please visit our artwork instruction pages at http://www.elsevier.com/artworkinstructions.
Electronic artwork
General points
• Make sure you use uniform lettering and sizing of your original artwork.
• Save text in illustrations as "graphics" or enclose the font.
• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Produce images near to the desired size of the printed version.
• Submit each figure as a separate file.
A detailed guide on electronic artwork is available on our website:
http://www.elsevier.com/artworkinstructions
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats
Regardless of the application used, when your electronic artwork is finalised, please "save as" or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
EPS: Vector drawings. Embed the font or save the text as "graphics".
TIFF: color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.
DOC, XLS or PPT: If your electronic artwork is created in any of these Microsoft Office applications please supply "as is".
Please do not:
• Supply embedded graphics in your wordprocessor (spreadsheet, presentation) document;
• Supply files that are optimised for screen use (like GIF, BMP, PICT, WPG); the resolution is too low;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Colour Illustrations
Colour illustrations online
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct resolution. Polaroid colour prints are not suitable. If, together with your accepted article, you submit usable colour figures then Elsevier will ensure, at no additional charge, that these figures will appear in colour on the Web (e.g. ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in colour in the printed version. For colour reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article. Please indicate your preference for colour in print or on the Web only. For further information on the preparation of electronic artwork, please see http://authors.elsevier.com/artwork.
Please note: Because of technical complications which can arise by converting colour figures to "grey scale" (for the printed version should you not opt for colour in print) please submit in addition usable black and white versions of all the colour illustrations.
Submission checklist
It is hoped that this list will be useful during the final checking of an article prior to sending it to the journal's Editor for review. Please consult this Guide for Authors for further details of any item.
Ensure that the following items are present:
One Author designated as corresponding Author:
• E-mail address
• Full postal address
• Telephone and fax numbers
All necessary files have been uploaded
• Keywords
• All figure captions
• All tables (including title, description, footnotes)
Further considerations
• Manuscript has been "spellchecked" and "grammar-checked"
• References are in the correct format for this journal
• All references mentioned in the Reference list are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Web)
• Color figures are clearly marked as being intended for color reproduction on the Web (free of charge) and in print or to be reproduced in color on the Web (free of charge) and in black-and-white in print
• If only color on the Web is required, black and white versions of the figures are also supplied for printing purposes
For any further information please visit our customer support site at http://support.elsevier.com.
Use of the Digital Object Identifier
The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic information. The correct format for citing a DOI is shown as follows (example taken from a document in the journal Physics Letters B):
doi:10.1016/j.physletb.2003.10.071
When you use the DOI to create URL hyperlinks to documents on the web, they are guaranteed never to change.
Proofs
Elsevier will do everything possible to get your article corrected and published as quickly and accurately as possible. Therefore, it is important to ensure that all of your corrections are sent back to us in one communication. Subsequent corrections will not be possible, so please ensure your first sending is complete.
Reprints
PDF offprints are provided free of charge. No reprints are provided free of charge. Reprints (50 copies minimum) can be ordered at quoted prices on order forms sent out together with the proofs.
For inquiries relating to the submission of articles (including electronic submission where available) please visit this journal's homepage. You can track accepted articles at http://www.elsevier.com/trackarticle and set up e-mail alerts to inform you of when an article's status has changed. Also accessible from here is information on copyright, frequently asked questions and more. Contact details for questions arising after acceptance of an article, especially those relating to proofs, will be provided by the publisher.
Editorial Board
Editor-in-Chief:
S. Humphries
London, UK, Email: rmhasle@ucl.ac.uk
Associate Editors:
S. Agewall
Oslo, Norway
R. Asmis
San Antonio, TX, USA
H. Barrett
Crawley, Australia
S. Calandra
Modena, Italy
A. Catapano
Milan, Italy
J.S. Cohn
Sydney, Australia
G. Dallinga-Thie
Amsterdam, The Netherlands
S. Devaraj
Sacramento, CA, USA
E. Emanuele
Robbio, Italy
G.P. Fadini
Padova, Italy
C. Falcone
Pavia, Italy
M. Federici
Rome, Italy
K. Kajinami
Kanazawa, Japan
W. Koenig
Ulm, Germany
F. Kronenberg
Innsbruck, Austria
M. Law
London, UK
A.P. Levy
Haifa, Israel
E.H. Moriguchi
Porto Alegre, Brazil
K. Nasir
Boston, MA, USA
L.B. Nielsen
Copenhagen, Denmark
P. Raggi
Atlanta, GA, USA
R.D. Santos
Sao Paulo, Brazil
C. Stehouwer
Maastricht, The Netherlands
L. Tannock
Lexington, KY, USA
G.F. Watts
Perth, Australia
P. Weinberg
London, UK
A. Zampelas
Athens, Greece
Reviews Editor:
A. von Eckardstein
Zürich, Switzerland, Email: arnold.voneckardstein@usz.ch
Supplements Editor:
A. Catapano
Milan, Italy, Email: alberico.catapano@gmail.com
Editorial Board:
T. Akasaka
Wakayama, Japan
M. Austin
Seattle, WA, USA
L. Badimon
Barcelona, Spain
P.J. Barter
Sydney, Australia
U. Beisiegel
Hamburg, Germany
A. Blann
Birmingham, UK
S.-M. Brand-Herrmann
Münster, Germany
G. Camejo
Mölndal, Sweden
G.R. Campbell
Queensland, Australia
M. Castro Cabezas
Rotterdam, The Netherlands
M.J. Chapman
Paris, France
A. Dominiczak
Glasgow, UK
Z.A. Fayad
New York, NY, USA
S.J. George
Bristol, UK
J. Golledge
Townsville, Australia
B. Griffin
Guildford, UK
D. Haskard
London, UK
M. Hofker
Groningen, The Netherlands
B.I. Hudson
New York, NY, USA
E. Hurt-Camejo
Göteborg, Sweden
A. Iglesias del Sol
Amsterdam, The Netherlands
H. Iso
Osaka, Japan
J.Y. Jeremy
Bristol, UK
W. Jessup
Sydney, Australia
I. Jialal
Sacramento, CA, USA
R.H. Karas
Boston, MA, USA
S. Kasayama
Osaka, Japan
G.M. Kostner
Graz, Austria
L. Kritharides
Sydney, Australia
I. Loftus
London, UK
M.I. Mackness
Reus, Spain
L. Masana
Reus, Spain
Y. Momiyama
Tokyo, Japan
E.D. de Muinck
Linköping, Sweden
Y. Nakamura
Kyoto, Japan
D. Neely
Newcastle upon Tyne, UK
P.J. Nestel
Melbourne, Australia
A. Newby
Bristol, UK
D. Panagiotakos
Athens, Greece
Z. Reiner
Zagreb, Croatia
R.S. Rosenson
New York, NY, USA
P. Rubba
Naples, Italy
L.L. Rudel
Winston-Salem, NC, USA
K. Saku
Fukuoka, Japan
V. Sansoy
Istanbul, Turkey
G. Schmitz
Regensburg, Germany
K.E. Suckling
Stevenage, UK
E.S. Tai
Singapore
A.J. Taylor
Washington, DC, USA
L. Tokgözoglu
Ankara, Turkey
O. Wiklund
Göteborg, Sweden
S. Yamashita
Osaka, Japan
R. Zechner
Graz, Austria
Editorial Assistants:
S. Leigh
London, UK
E. Spencer
London, UK
|
